Opening https://www.globenewswire.com/news-release/2023/03/14/2627221/0/en/Affimed-Announces-Presentations-of-Clinical-Data-from-AFM13-Phase-2-REDIRECT-and-Pre-clinical-Data-Demonstrating-CD16A-Shedding-Facilitates-Repetitive-Targeting-of-Tumor-Cells-by-A.html